Literature DB >> 9443169

Differences in drug prescribing patterns in elderly parkinsonian patients identified at hospital admission.

V F Trewin1, C J Lawrence, A J Abdulla, V R Pearce, G B Veitch, M Roach.   

Abstract

In the period July 1984 to June 1993 a total of 4541 admissions to a Department of Medicine for the Elderly were investigated. Approximately 9% of the total were diagnosed to have parkinsonism. Full drug histories together with the available demographic and clinical data were investigated in order to identify differences in the prescribing patterns in this group compared to those of non-parkinsonian patients admitted during this time frame. There was a statistically significant lower incidence among the parkinsonian group for the prescribing of all cardiovascular drug groups, anticoagulants, hypoglycaemics, bronchodilators, and corticosteroids compared with non-parkinsonian patients. In contrast, the incidence of hypnotics, laxatives, antidepressants and antipsychotics were significantly higher.

Entities:  

Mesh:

Year:  1997        PMID: 9443169     DOI: 10.1023/a:1008669826178

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  11 in total

1.  Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients.

Authors:  R D Sweet; F H McDowell
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Hypotensive effect of long-term levodopa in patients with Parkinson's disease.

Authors:  S Iwasaki; K Hamaguchi; A Iwasaki; M Takakusagi; Y Narabayashi
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

3.  The design of an algorithm for pharmacists to evaluate ADRs in the elderly.

Authors:  V F Trewin
Journal:  J Clin Pharm Ther       Date:  1991-02       Impact factor: 2.512

4.  Psychiatric aspects of Parkinson's disease.

Authors:  R C Baldwin; E J Byrne
Journal:  BMJ       Date:  1989-07-01

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.

Authors:  G Durrieu; J M Senard; M A Tran; A Rascol; J L Montastruc
Journal:  Clin Neuropharmacol       Date:  1991-02       Impact factor: 1.592

7.  Parkinson's disease and hypertension: chronic bromocriptine treatment.

Authors:  J L Montastruc; B Chamontin; A Rascol
Journal:  Neurology       Date:  1985-11       Impact factor: 9.910

Review 8.  Parkinsonism--drug treatment: Part I.

Authors:  M J Berg; B Ebert; D K Willis; T Host; R W Fincham; D D Schottelius
Journal:  Drug Intell Clin Pharm       Date:  1987-01

9.  The effects of dopamine agonists on human cardiovascular and sympathetic nervous systems.

Authors:  M G Ziegler; B Kennedy; O B Holland; D Murphy; C R Lake
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1985-04

10.  A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brain.

Authors:  G Micieli; E Martignoni; G Bono; A Cavallini; F Rossi; R Horowski; G Nappi
Journal:  Clin Neuropharmacol       Date:  1989-10       Impact factor: 1.592

View more
  1 in total

1.  Impact of Antidepressants on Cardiac Events and All-Cause Mortality in Parkinson's Disease: A National Data-Linkage Study.

Authors:  Khalid Orayj
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-30       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.